AVXL Clinical trials Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease Published August 20, 2025 at 11:30 AM Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Find similar articles on Candlesense globenewswire